BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,717 | -37.7% | 119,762 | +9.6% | 0.01% | -33.3% |
| Q2 2023 | $551,930 | +1246.2% | 109,293 | +632.0% | 0.01% | +1100.0% |
| Q1 2022 | $41,000 | -48.8% | 14,931 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $80,000 | -36.5% | 14,931 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $126,000 | -51.4% | 14,931 | -29.8% | 0.00% | -62.5% |
| Q2 2021 | $259,000 | -45.1% | 21,284 | +9.4% | 0.01% | -55.6% |
| Q1 2021 | $472,000 | -59.9% | 19,449 | -47.1% | 0.02% | -59.1% |
| Q4 2020 | $1,178,000 | -9.1% | 36,761 | -14.3% | 0.04% | -43.6% |
| Q3 2020 | $1,296,000 | +39.5% | 42,874 | +94.6% | 0.08% | +21.9% |
| Q2 2020 | $929,000 | – | 22,028 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |